HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase Mutants
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase Mutants
Authors
Keywords
-
Journal
ACS Infectious Diseases
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2021-03-09
DOI
10.1021/acsinfecdis.0c00819
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural basis for strand-transfer inhibitor binding to HIV intasomes
- (2020) Dario Oliveira Passos et al. SCIENCE
- Structural basis of second-generation HIV integrase inhibitor action and viral resistance
- (2020) Nicola J. Cook et al. SCIENCE
- HIV-1 Integrase Inhibitors that are active against Drug-Resistant Integrase Mutants
- (2020) Steven J. Smith et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cabotegravir Plus Rilpivirine: First Approval
- (2020) A. Markham DRUGS
- Structural Biology of HIV Integrase Strand Transfer Inhibitors
- (2020) Ilona K. Jóźwik et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Molecular design opportunities presented by solvent‐exposed regions of target proteins
- (2019) Xiangyi Jiang et al. MEDICINAL RESEARCH REVIEWS
- Antiviral activity of HIV‐1 integrase strand‐transfer inhibitors against mutants with integrase resistance‐associated mutations and their frequency in treatment‐naïve individuals
- (2019) Nicolas A. Margot et al. JOURNAL OF MEDICAL VIROLOGY
- HIV-1 integrase inhibitors that are broadly effective against drug-resistant mutants
- (2018) Steven J. Smith et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer Inhibitors
- (2018) Hanh T Pham et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
- (2018) Steven J. Smith et al. Retrovirology
- Success and failure of initial antiretroviral therapy in adults
- (2018) Andrew Carr et al. AIDS
- Structure-Guided Optimization of HIV Integrase Strand Transfer Inhibitors
- (2017) Xue Zhi Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Paying the Price of Desolvation in Solvent-Exposed Protein Pockets: Impact of Distal Solubilizing Groups on Affinity and Binding Thermodynamics in a Series of Thermolysin Inhibitors
- (2017) Jonathan Cramer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cryo-EM structures and atomic model of the HIV-1 strand transfer complex intasome
- (2017) Dario Oliveira Passos et al. SCIENCE
- HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant Integrases
- (2016) Xue Zhi Zhao et al. ACS Chemical Biology
- Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile
- (2016) Manuel Tsiang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Improving Viral Protease Inhibitors to Counter Drug Resistance
- (2016) Nese Kurt Yilmaz et al. TRENDS IN MICROBIOLOGY
- Diffraction-geometry refinement in theDIALSframework
- (2016) David G. Waterman et al. Acta Crystallographica Section D-Structural Biology
- Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors
- (2015) Izzat T. Raheem et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
- (2014) A. Castagna et al. JOURNAL OF INFECTIOUS DISEASES
- 4-Amino-1-hydroxy-2-oxo-1,8-naphthyridine-Containing Compounds Having High Potency against Raltegravir-Resistant Integrase Mutants of HIV-1
- (2014) Xue Zhi Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effect of HIV-1 Integrase Resistance Mutations When Introduced into SIVmac239 on Susceptibility to Integrase Strand Transfer Inhibitors
- (2014) S. A. Hassounah et al. JOURNAL OF VIROLOGY
- Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
- (2014) Steven J. Smith et al. Jove-Journal of Visualized Experiments
- How good are my data and what is the resolution?
- (2013) Philip R. Evans et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Decision making inxia2
- (2013) Graeme Winter et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Biochemical Analysis of the Role of G118R-Linked Dolutegravir Drug Resistance Substitutions in HIV-1 Integrase
- (2013) Peter K. Quashie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Substrate Envelope-Designed Potent HIV-1 Protease Inhibitors to Avoid Drug Resistance
- (2013) Madhavi N.L. Nalam et al. CHEMISTRY & BIOLOGY
- Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
- (2013) Pedro Cahn et al. LANCET
- Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
- (2013) Francois Raffi et al. LANCET
- Activities, Crystal Structures, and Molecular Dynamics of Dihydro-1H-isoindole Derivatives, Inhibitors of HIV-1 Integrase
- (2012) Mathieu Métifiot et al. ACS Chemical Biology
- 3′-Processing and strand transfer catalysed by retroviral integrasein crystallo
- (2012) Stephen Hare et al. EMBO JOURNAL
- Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study
- (2012) Joseph J. Eron et al. JOURNAL OF INFECTIOUS DISEASES
- Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults
- (2011) Sherene Min et al. AIDS
- In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4
- (2011) Nicolas A. Margot et al. ANTIVIRAL RESEARCH
- Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir
- (2011) P. K. Quashie et al. JOURNAL OF VIROLOGY
- Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial
- (2011) Jan van Lunzen et al. LANCET INFECTIOUS DISEASES
- The Phenix software for automated determination of macromolecular structures
- (2011) Paul D. Adams et al. METHODS
- Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572)
- (2011) S. Hare et al. MOLECULAR PHARMACOLOGY
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- In VitroAntiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor
- (2010) Masanori Kobayashi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Retroviral intasome assembly and inhibition of DNA strand transfer
- (2010) Stephen Hare et al. NATURE
- Structure-based modeling of the functional HIV-1 intasome and its inhibition
- (2010) L. Krishnan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance
- (2010) S. Hare et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Loss of Raltegravir Susceptibility by Human Immunodeficiency Virus Type 1 Is Conferred via Multiple Nonoverlapping Genetic Pathways
- (2009) S. Fransen et al. JOURNAL OF VIROLOGY
- Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro
- (2008) I. Malet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Integration of Rous Sarcoma Virus DNA: a CA Dinucleotide Is Not Required for Integration of the U3 End of Viral DNA
- (2008) J. Oh et al. JOURNAL OF VIROLOGY
- Resistance Mutations in Human Immunodeficiency Virus Type 1 Integrase Selected with Elvitegravir Confer Reduced Susceptibility to a Wide Range of Integrase Inhibitors
- (2008) O. Goethals et al. JOURNAL OF VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search